AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06158529 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: spinal cord stimulator
Description: A spinal cord stimulator is an implanted device that sends low levels of electricity directly into the spinal cord to relieve pain.
Study NCT06158529 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: high frequency spinal cord stimulation
Description: A spinal cord stimulator is an implanted device that sends low levels and high frequency of electricity directly into the spinal cord to relieve pain.
Study NCT06261879 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Special sanitary pad
Description: The special sanitary pad is similar to the normal sanitary pad with 0.01 agar gel only. The agar gel is an approved source of food.
Study NCT05885308 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Otago
Description: Group training is compared with training performed at participants' homes, using an online film
Study NCT05885308 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Otago
Description: Group training is compared with training performed at participants' homes, using an online film
Study NCT04378426 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nitrous Oxide
Description: PTSD participants in this arm will receive and admixture of up to 50% nitrous oxide and 50% oxygen plus intravenous saline
Study NCT04378426 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Midazolam
Description: PTSD participants in this arm will receive and admixture of up to 50%nitrogen and 50% oxygen plus intravenous 0.045mg/kg midazolam
Study NCT04378426 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nitrogen
Description: PTSD participants in this arm will receive and admixture of up to 50%nitrogen and 50% oxygen plus intravenous 0.045mg/kg midazolam
Study NCT04378426 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxygen
Description: inhaled gas
Study NCT04378426 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxygen
Description: inhaled gas
Study NCT04378426 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Saline
Description: Placebo infusion
Study NCT04904861 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Videoconference intervention group
Description: A short face-to-face dyadic group workshop focused on increasing maternal sensitivity was adapted to be carried out virtually by videoconference. The intervention considers 4 sessions, with a weekly frequency, with a minimum of 3 and a maximum of 6 dyads per group led by a monitor (psychologist). The activities are protocolized in a manual and are designed to be carried out by the mother with the baby under one year of age. .
Study NCT04947293 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Physical activity
Description: Both groups will practice a physical activity adapted to their motor skills. They will have two group sessions (maximum 5 people per group) in a face-to-face setting, and one independent session at home supported by a video, each week. These programs last 12 weeks, and will be supervised by the same person, a physiotherapist.
Study NCT04947293 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical activity
Description: Both groups will practice a physical activity adapted to their motor skills. They will have two group sessions (maximum 5 people per group) in a face-to-face setting, and one independent session at home supported by a video, each week. These programs last 12 weeks, and will be supervised by the same person, a physiotherapist.
Study NCT05350787 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ThisCART19A
Description: ThisCART19A is a new type CAR-T cells therapy for patients with acute B-cell leukemia
Study NCT04904861 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control group
Description: Psycho-educational intervention : They will receive brochures with information on parenting (once a week for 4 weeks) in addition to the usual care in their primary care center
Study NCT05653375 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mindfulness-based psychoeducation program
Description: In this study, a mindfulness-based psychoeducation program was applied to the experimental group, 2 times a week for 4 weeks, with a total of 8 sessions, including methods such as meditation, body scanning, mindful eating, and breathing work. Measurement tools were applied to the experimental and control groups before and after the program.
Study NCT05653375 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: ongoing life
Description: The control group continued with their lives without any intervention. Only pre-test and post-test were applied. While the program was applied to the experimental group, no intervention was made to the control group.
Study NCT05872048 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: periodontal distractor
Description: custom made device from hyrex screw
Study NCT05994170 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Reduction CTVp1
Description: High Risk Primary Tumor Clinical Target Volumes (CTVp1) is defined as 5mm margin from GTVp,including pre-induction chemotherapy tumor extension( CTVp1=GTVp+5mm)
Study NCT05994170 — intervention group
Intervention type: RADIATION
Group type: PLACEBO_COMPARATOR
Intervention: Non-reduction CTVp1
Description: High Risk Primary Tumor Clinical Target Volumes (CTVp1) is defined as whole nasopharynx as well as 5mm margin from GTVp( CTVp1=GTVp+5mm+whole nasopharynx)
Study NCT05191043 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesio Taping Technique
Description: Kinesio taping is a thin, stretchy, elastic cotton strip with an acrylic adhesive that is approximately the same thickness as the epidermis of the skin. When the taping method is followed correctly, the tape effects on the muscle by facilitating a weakened muscle or relaxing an over-used muscle,decreasing pain, fatigue and increasing tissue recovery. Kinesio Taping facilitation technique will be used with fifty percent stretch on rhomboids bilaterally.
Study NCT05191043 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Routine Physical Therapy
Description: routine physical therapy includes thermotherapy and Transcutaneous electrical nerve stimulation (TENS), the strengthening exercises of lower and middle trapezius, rhomboids and deep neck flexors. Stretching exercises of upper trapezius, pectoralis major and minor. Mobilization of cervicothoracic junction and postural education.~Thermotherapy and transcutaneous electrical nerve stimulation will be used for 10 minutes in each session. Each exercise will be performed in 3 sets of 10 repetitions. Treatment session will have a duration of 30-45 minutes.
Study NCT05191043 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Routine Physical Therapy
Description: routine physical therapy includes thermotherapy and Transcutaneous electrical nerve stimulation (TENS), the strengthening exercises of lower and middle trapezius, rhomboids and deep neck flexors. Stretching exercises of upper trapezius, pectoralis major and minor. Mobilization of cervicothoracic junction and postural education.~Thermotherapy and transcutaneous electrical nerve stimulation will be used for 10 minutes in each session. Each exercise will be performed in 3 sets of 10 repetitions. Treatment session will have a duration of 30-45 minutes.
Study NCT06455267 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Now Foods L-Ornithine Capsules
Description: L-ornithine is an amino acid that helps the liver clear toxic ammonia and plays an important role in liver protection and treatment of hepatic encephalopathy. Now Foods L-ornithine capsules are an ornithine supplement containing 500mg of L-ornithine per capsule. Patients in the L-ornithine supplementation group take ornithine capsules orally twice a day, three capsules each time, for 8 weeks.
Study NCT05758701 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Iodinated Contrast Agent (Omnipaque)
Description: Standard dosage of Omnipaque for CT imaging is 100 ml. Cohort will be given a reduced dosage.
Study NCT05758701 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dual Energy CT
Description: Dual energy CT scanners enable monoenergetic CT image reconstruction which allows for improved iodine image contrast.
Study NCT04754945 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bortezomib
Description: Given SC
Study NCT04754945 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Given IV or PO
Study NCT04754945 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Given IV or PO
Study NCT04754945 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Isatuximab
Description: Given IV
Study NCT06386458 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AThrough radiofrequency transseptal puncture system
Description: Utilizing AThrough radiofrequency transseptal puncture system for left atrial access
Study NCT06386458 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Traditional mechanical transseptal puncture needle
Description: Utilizing Traditional mechanical transseptal puncture needle for left atrial access
Study NCT06329128 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental: Study Group
Description: A 15-session (5 days a week / 3 weeks) physiotherapy and rehabilitation (electrotherapy and home program) program will be applied to both groups.~Electrotherapy application; It will consist of Hotpack (15 minutes), TENS (20 minutes), Ultrasound (10 minutes) applications. For the home program, a program consisting of isometric and isotonic exercises will be given to the muscles around the knee. The home program will be followed with an exercise diary.~In the manual therapy group, in addition to the above treatment, manual therapy will be given 3 days a week. The content of the manual therapy program is as follows;~* Patellofemoral joint superior-inferior mobilization~* Medial-lateral mobilization with active knee flexion~* Tibiofemoral joint ventral (anterior-posterior) mobilization~* Tibiofemoral traction mobilization
Study NCT06329128 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Active Comparator: Control Group
Description: A 15-session (5 days a week / 3 weeks) physiotherapy and rehabilitation (electrotherapy and home program) program will be applied to both groups.~Electrotherapy application; It will consist of Hotpack (15 minutes), TENS (20 minutes), Ultrasound (10 minutes) applications. For the home program, a program consisting of isometric and isotonic exercises will be given to the muscles around the knee. The home program will be followed with an exercise diary.
Study NCT06220890 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Tooth preparation in Class IV lesions with 2mm bevel
Description: Class IV cavity with 2 mm bevel will be restored with nano-filled composite and clinical performance will be evaluated based on FDI criteria.
Study NCT06220890 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Tooth preparation in Class IV lesions with 2mm stair-step chamfer
Description: Class IV cavity with 2 mm stair step chamfer will be restored with nano-filled composite and clinical performance will be evaluated based on FDI criteria.
Study NCT05941936 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: LM103
Description: Fresh tumor samples will be resected from enrolled patients. Autologous TILs will be extracted and reinfused to corresponding patients after ex vivo stimulation, activation and extensive expansion.
Study NCT05519293 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: H002
Description: Small molecule, Capsule
Study NCT06092125 — intervention group
Intervention type: DEVICE
Intervention: PET/MR
Description: PET/MR device is used for pre-treatment evaluation and efficacy follow-up of four types of diseases
Study NCT05610189 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tavapadon
Description: Oral tablets
Study NCT05786274 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Cerebral autoregulation monitoring
Description: Perioperative characterization of cerebral autoregulation and autonomic function; characterization of adverse events after surgery
Study NCT06312488 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Clot Pro
Description: This study enrolls patients admitted to the Adult ICU of Milan Policlinico Hospital with a diagnosis of sepsis or septic shock. A ClotPro® TPA test is performed at admission and on day 1, 2, 3, and 7. Specific markers of coagulation (PAI-1, Plasminogen, Protein C and S) and inflammation (Il-1beta, IL-6, IL-8, TNF-alpha, ADM) are tested at enrollment. Routine laboratory tests are performed daily. Hemorrhagic and thrombotic events are searched. The study ends at 28 days or upon ICU discharge.
Study NCT05240443 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bariatric Surgery + Medical Management of CKD.
Description: The intervention group will include medical management and bariatric surgery, which will consist of Roux-en-Y gastric bypass or sleeve gastrectomy performed according to local practice standards. Medical management for CKD will be directed by nephrologists at St. Joseph's Healthcare Hamilton. Comorbidities such as hypertension, dyslipidemia, and type 2 diabetes will be managed at the discretion of individual nephrologists. Generally, this can include anti-hypertensives (angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) for systolic blood pressure control below a target of \<140/90 mmHg (\<130/80 in patients with type 2 diabetes), statins in patients with dyslipidemia to target low-density lipoprotein \<2mmol/L for the treatment of CKD.
Study NCT05240443 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Medical Management for CKD
Description: Medical management for CKD will be directed by nephrologists at St. Joseph's Healthcare Hamilton. Comorbidities such as hypertension, dyslipidemia, and type 2 diabetes will be managed at the discretion of individual nephrologists. Generally, this can include anti-hypertensives (angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) for systolic blood pressure control below a target of \<140/90 mmHg (\<130/80 in patients with type 2 diabetes), statins in patients with dyslipidemia to target low-density lipoprotein \<2mmol/L for the treatment of CKD.
Study NCT04630574 — intervention group
Intervention type: OTHER
Intervention: Speech evaluation with the clinical evaluation of dysarthria
Description: A first speech evaluation with the clinical evaluation of dysarthria during 30 minutes is proposed to exclude very severe dysarthria.
Study NCT04630574 — intervention group
Intervention type: OTHER
Intervention: complete assessment of the MonPaGe computerized protocol
Description: The application records directly and anonymously stores speech productions made by the patient.
Study NCT05220735 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Omega-3 long chain polyunsaturated fatty acids (n-3 LCPUFA)
Description: 3 three fish oil capsules providing 2.1 g n-3 PUFA; 1.27 g Docosahexanoic acid (DHA) and 0.86 g Eicosapentanoic acid (EPA) capsules.~The absorption study test meals will consist of white bread with butter and honey, 6mg of labeled iron as ferrous sulfate and 300 g of distilled water. The meal will be given on two days without and with ascorbic acid. The test meals without ascorbic acid will contain 6 mg 57Fe as ferrous sulfate whereas the meals containing ascorbic acid will contain 6 mg 58Fe as ferrous sulfate.
Study NCT05662111 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Etidronate
Description: The dosage of etidronate is 20 mg/kg for twee weeks and ten weeks off. Etidronate is given in capsules of 200 mg. Etidronate capsules are administered orally. During the study, participants will receive etidronate in four periods of two weeks during the twelve months of follow-up.
Study NCT05662111 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo is given in capsules and are administered orally. During the study, participants will receive placebo in four periods of two weeks during the twelve months of follow-up.
Study NCT05278481 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Reward Message with standard introduction
Description: Each text message will be sent 6 times total over two weeks. Each message type will be combined with a standard introduction.
Study NCT05278481 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Reward Message with culturally tailored introduction
Description: Each text message will be sent 6 times total over two weeks. Each message type will be combined with an introduction culturally tailored for Hispanic/Latino participants.
Study NCT05278481 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Threat/Self-efficacy with standard introduction
Description: Each text message will be sent 6 times total over two weeks. Each message type will be combined with a standard introduction.
Study NCT05278481 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Threat/Self-efficacy with culturally tailored introduction
Description: Each text message will be sent 6 times total over two weeks. Each message type will be combined with an introduction culturally tailored for Hispanic/Latino participants.
Study NCT05278481 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Social norms message with standard introduction
Description: Each text message will be sent 6 times total over two weeks. Each message type will be combined with a standard introduction.
Study NCT05278481 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Social norms message with culturally tailored introduction
Description: Each text message will be sent 6 times total over two weeks. Each message type will be combined with an introduction culturally tailored for Hispanic/Latino participants.
Study NCT05943080 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PCI (0.25% marcaine+ 2.0 μg/mL of adrenaline + %0.9 saline)
Description: The application is made into the anatomical space between the posterior capsule and the popliteal artery before implantation.
Study NCT05943080 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IPACK(0.25% marcaine+ 2.0 μg/mL of adrenaline + %0.9 saline)
Description: It is applied to the anatomical space between the posterior capsule and the popliteal artery with the help of USG.
Study NCT05943080 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: ACB ( 0.25% marcaine + %0.9 saline)
Description: It is inserted into the adductor canal by simultaneous imaging of the needle, accompanied by ultrasonography, from the level just below the sartorius muscle.
Study NCT05943080 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ACB ( 0.25% marcaine + %0.9 saline)
Description: It is inserted into the adductor canal by simultaneous imaging of the needle, accompanied by ultrasonography, from the level just below the sartorius muscle.
Study NCT05564559 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: multifamily group psychoeducation
Description: The intervention involves 8 weeks of multifamily psychoeducation for families. Duration of sessions: 75 minutes on average Context: First session: psychoeducation on substance-abuse disorders; second session; effects of addiction on the family; third session; illness management; fourth session; supporting recovery; fifth session; improving stress coping skills/stress management; sixth session; developing problem-solving skills; seventh session; strengthening the family; eighth session; working with stigma Preferred approach: face-to-face, multi-family Approach: Psychoeducation
Study NCT05646810 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Lidocaine (10 mg/ml)
Description: Lidocaine (10 mg/ml) will be injected according to established protocols using ultrasound guidance and an aseptic technique by an experienced anesthesiologist.
Study NCT05646810 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: PLACEBO_COMPARATOR
Intervention: Isotonic saline
Description: Isotonic saline will be injected according to established protocols using ultrasound guidance and an aseptic technique by an experienced anesthesiologist.
Study NCT06202248 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Experimental: DaRT seeds
Description: Intratumoral Diffusing alpha-emitters Radiation Therapy (DaRT) Seeds
Study NCT04739384 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ticagrelor 90mg
Description: Ticagrelor 90 mg followed by Ticagrelor 60 mg
Study NCT04739384 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ticagrelor 60 mg
Description: Ticagrelor 60 mg followed by Ticagrelor 90 mg
Study NCT06225622 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irinotecan Liposome
Description: In dose escalation study, irinotecan liposome injection will be administered by an intravenous infusion at three doses of 60 mg/m2, 70 mg/m2 and 80 mg/m2, d1, 14 days per cycle. In expansion study, irinotecan liposome injection will be administered by an intravenous infusion at the dose of RP2D, d1, 14 days per cycle.~Until the disease progresses or surgery is possible.
Study NCT06225622 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: 85 mg/m2, intravenously infusion, d1, 14 days per cycle, up to 12 cycles.
Study NCT06225622 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5-FU
Description: 2400mg/m2, intravenous infusion, d1-2, 14 days per cycle. Until the disease progresses or surgery is possible.
Study NCT06225622 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LV
Description: 400mg/m2, intravenous infusion, d1, 14 days per cycle. Until the disease progresses or surgery is possible.
Study NCT06225622 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: 5mg/kg, intravenous infusion, d1, 14 days per cycle. Until the disease progresses or surgery is possible.It is used to patients in dose escalation phase and with gene mutation in extension phase.